13 key notes on VEPTR for early-onset scoliosis correction
The second article was an analysis of complications. This retrospective study was conducted on prospectively collected data from 2007 to 2012 from eight sites. Every patient had at least four surgical procedures. There were 213 patients who had 55 ...
Becker's Orthopedic & Spine - Tue, 25 Nov 2014 13:00



Why On-farm Culturing Merits a Closer Look
With targeted treatment, the goal is a better response to treatment of infections caused by gram positive pathogens like staphylococci (staph) and some environmental streps. A recent study looked at the cost effectiveness of using on-farm culturing to ...
AgWeb (blog) - Mon, 24 Nov 2014 11:41



Carbon Monoxide Could Play Key Role in Killing Bacterial Lung Infections
CO and lung disease In a new study entitled “Macrophages sense and kill bacteria through carbon monoxide–dependent inflammasome activation” the authors discovered that carbon monoxide (CO) released by macrophages is a key factor in the host ...
Lung Disease News - Wed, 19 Nov 2014 04:24

Scientists Identify a Role for Carbon Monoxide in Battling Bacterial Infections
Newswise — BOSTON – The innate immune system serves as the body's specialized armed forces division, comprised of a host of defense mechanisms used to battle bacterial infections. ... Wegiel, PhD, an investigator in BIDMC's Division of Transplantation ...
Newswise (press release) - Tue, 11 Nov 2014 06:15

CO Fights Bacterial Infections
Laboratory Equipment - Tue, 11 Nov 2014 04:11

Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer
On May 23, 2014, the FDA approved DALVANCETM for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) ...
CNNMoney - Mon, 17 Nov 2014 05:10



Resistance Risk Rises With Longer Hospital Stay
Smith, Bosso, and colleagues analyzed a database of Gram-negative multidrug-resistant infections recorded at the hospital and compared the day of infection with the day of hospital stay. All told, they analyzed 980 isolates, ... The "elephant in the ...
MedPage Today - Tue, 18 Nov 2014 16:22

Theravance Biopharma, Inc. Reports Third Quarter 2014 Financial Results
VIBATIV is a bactericidal, once-daily injectable antibiotic discovered internally, to treat patients with serious, life-threatening infections due to Staphylococcus aureus and other Gram-positive bacteria, including methicillin-resistant (MRSA) strains ...
CNNMoney - Thu, 06 Nov 2014 14:00



New antibiotic-free method to treat infections
There have been increasing numbers of different types of bacteria that have become resistant to some antibiotics: Tuberculosis, some forms of Staphylococcus aureus, some Enterococci, strains of gonorrhea and others. The “classic” antibiotics that used ...
AMERICAblog (blog) - Fri, 07 Nov 2014 07:18


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014